Molecular Pharmacology Group, Division of Molecular Pharmacology and Phytochemistry, Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group, Cikarang, Indonesia.
Cancer Biol Ther. 2010 Oct 15;10(8):814-23. doi: 10.4161/cbt.10.8.13085.
Phaleria macrocarpa, also known as Mahkota dewa, is an Indonesian native plant that has been used as a remedy for many diseases. However, the molecular mechanism of Phaleria macrocarpa is still limited. In this study, we evaluate its molecular mechanism using a bioactivity-guided DLBS1425, an extract of Phaleria macrocarpa on MDA-MB-231 breast cancer cell line. DLBS1425 exhibited inhibition of proliferative, migratory and invasive potential of MDA-MB-231 in a dose-dependent manner, and significantly reduced phosphoinositide-3 (PI3)-kinase/protein kinase B (AKT) signalling by reducing PI3K transcript level and subsequent reduction in AKT phosphorylation. Further, it induced pro-apoptotic genes including BAX, BAD and PUMA and consequently induces cellular death signal by caspase-9 activation, promoting PARP cleavage and DNA fragmentation. Our results suggest that DLBS1425 is a potential anticancer agent which targets genes involved in both cell survival and apoptosis in MDA-MB-231 breast cancer cells.
巨荔枝,又称桂木,是印度尼西亚的本地植物,被用于治疗许多疾病。然而,巨荔枝的分子机制仍然有限。在这项研究中,我们使用生物活性导向的 DLBS1425 评估了其分子机制,DLBS1425 是巨荔枝的提取物,对 MDA-MB-231 乳腺癌细胞系具有抑制增殖、迁移和侵袭的潜力,并通过降低 PI3K 转录水平和随后减少 AKT 磷酸化来显著降低磷酸肌醇-3(PI3)-激酶/蛋白激酶 B(AKT)信号。此外,它诱导促凋亡基因,包括 BAX、BAD 和 PUMA,随后通过 caspase-9 激活诱导细胞死亡信号,促进 PARP 切割和 DNA 片段化。我们的结果表明,DLBS1425 是一种潜在的抗癌剂,它靶向与 MDA-MB-231 乳腺癌细胞中的细胞存活和凋亡相关的基因。